- Report
- October 2023
- 74 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- August 2022
- 100 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- May 2022
- 40 Pages
Poland
From €1466EUR$1,500USD£1,224GBP
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
Vietnam
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
United States
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
South Korea
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
Saudi Arabia
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
Russia
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
Japan
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
Ireland
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
India
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
Germany
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
France
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
China
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 40 Pages
Brazil
From €1466EUR$1,500USD£1,224GBP
- Report
- March 2023
- 30 Pages
Global
€11969EUR$12,250USD£9,992GBP
- Training
- 90 Minutes
Global
- Newsletter
- November 2024
- 3 Pages
Europe
From €128EUR$131USD£107GBP
The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms.
The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more